PEAR

Pear Therapeutics (PEAR)

Pear Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PEAR

1 2 3 4 5 6 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/05/03	02 : 37	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/04/13	05 : 34	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/04/11	05 : 37	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/04/08	00 : 33	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/04/08	00 : 30	Business Wire	Pear Therapeutics Files for Chapter 11 and Will Seek to Sell Assets Through Sales Process	NASDAQ:PEAR	Pear Therapeutics Inc
2023/04/04	05 : 05	GlobeNewswire Inc.	Sight Sciences Appoints Ali Bauerlein as Chief Financial Officer	NASDAQ:PEAR	Pear Therapeutics Inc
2023/04/01	05 : 04	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/03/17	22 : 15	Business Wire	Pear Therapeutics Announces Process Exploring Strategic Alternatives	NASDAQ:PEAR	Pear Therapeutics Inc
2023/02/27	22 : 00	Business Wire	Pear Therapeutics to Participate in 43rd Annual Cowen Healthcare Conference	NASDAQ:PEAR	Pear Therapeutics Inc
2023/02/25	06 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/02/10	06 : 43	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/02/02	22 : 00	Business Wire	Pear Therapeutics to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/26	22 : 00	Business Wire	Pear Therapeutics and BrightView Health Expand Pilot Program to Provide Prescription Digital Therapeutics for the Treatment of Substance Use Disorders	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/25	06 : 08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/25	06 : 08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/25	06 : 07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/25	06 : 07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/19	07 : 06	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/19	07 : 02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/19	07 : 02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/19	07 : 02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/18	22 : 00	Business Wire	Pear Therapeutics Announces Inclusion of reSET® and reSET-O® on the January 2023 Florida Medicaid Preferred Drug List	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/17	22 : 00	Business Wire	Pear Therapeutics to Participate in Citi’s BioTech C-Suite Virtual Fireside Chat Series	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/12	22 : 00	Business Wire	California Department of Health Care Services Awards Contract to Pear Therapeutics to Support the Recovery Incentives Program	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/11	06 : 21	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/10	22 : 00	Business Wire	Pear Therapeutics and COEUS Healthcare Partner to Combat the Addiction Crisis With Prescription Digital Therapeutics	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/05	06 : 21	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/04	22 : 00	Business Wire	Pear Therapeutics and Spero Health to Expand Access to Prescription Digital Therapeutics for People in Recovery Across Multiple Locations and States	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/04	20 : 03	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/03	21 : 38	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:PEAR	Pear Therapeutics Inc